-
HC Wainwright Reiterates "Buy" Rating for Innate Pharma (NASDAQ:IPHA)
Source: Buzz FX / 07 Feb 2025 09:32:10 America/New_York
HC Wainwright Reiterates "Buy" Rating for Innate Pharma (NASDAQ:IPHA) Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Innate Pharma ( NASDAQ:IPHA - Get Free Report ) 's stock had its "buy" rating restated by investmen
Read more...